Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.
about
The Production Processes and Biological Effects of Intravenous ImmunoglobulinCD4 and CD8 subpopulation changes during high dose intravenous immunoglobulin treatment.Recurrent cerebral infarction and the antiphospholipid syndrome: effect of intravenous gammaglobulin in a patient with systemic lupus erythematosus.High dose intravenous gammaglobulins in autoimmune disorders: mode of action and therapeutic uses.Long-term response in a patient with ITP following low dose anti-D immunoglobulin therapy.The use and mechanisms of action of intravenous immunoglobulin: an update.Mechanism of action of intravenous immunoglobulin in immune-mediated cytopenias.Harmful and beneficial antibodies in immune thrombocytopenic purpura.Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial.Clinical evaluation of plasma exchange and high dose intravenous immunoglobulin in a patient with Isaacs' syndrome.Immune tolerance induction: recombinant vs. human-derived product.Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).Intravenous immunoglobulin prevents murine antibody-mediated acute lung injury at the level of neutrophil reactive oxygen species (ROS) productionHealthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies.Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.Treatment of vasculitis.Spontaneous reversal of acquired autoimmune dysfibrinogenemia probably due to an antiidiotypic antibody directed to an interspecies cross-reactive idiotype expressed on antifibrinogen antibodiesRecovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.The concept of idiotypic vaccination against factor VIII inhibitors in haemophilia A.Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies.Pathophysiology of inhibitors to factor VIII in patients with haemophilia A.Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.IVIG--mechanisms of action.Modulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins: a possible mechanism of action in vascular diseasesImmune tolerance therapy in patients with acquired hemophilia.IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients.Immunocompetent autoreactive B lymphocytes are activated cycling cells in normal mice.Intravenous IgG: A New Therapeutic ToolThe diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.Acquired hemophilia A.High-dose intravenous gammaglobulin therapy for acquired von Willebrand diseaseMeeting report: ninth and tenth workshops of the European Paediatric Network for Haemophilia Management (PedNet).International recommendations on the diagnosis and treatment of patients with acquired hemophilia AAcquired hemophilia in a patient with systemic lupus erythematosus: a case report and literature review.Complications of hemophilia A treatment: factor VIII inhibitors.Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.Tolerance to factor VIII inhibitors in hemophilia A patients: a French twist.Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies.Intravenous immunoglobulin therapy for autoimmune diseases.
P2860
Q26752540-5E444127-0357-4171-8D78-54BD7FBCA25AQ33386475-D3763EFF-C7F5-4A7E-B949-2D2D31A0CCC7Q33401106-6633BC93-9D66-44F2-BC68-AC1F780DF79EQ33415447-0D788EB0-D898-4CB6-8BE0-0870907CDE69Q33420004-C9535D6C-2A04-4AA6-B8A6-F7188FADB6F6Q33428635-9A9AD82E-AADB-4B91-9DD8-3490F3537DEBQ33446069-8FF670DF-B347-4F07-8628-3B2351956143Q33491681-21910A42-FE4B-4075-BBA1-D52241B9E91BQ33596386-0656B6E1-A751-4FA7-99D0-156B62D8CE6FQ33732789-8A3246EB-736D-4EBB-B128-B439C8000514Q34117221-5A5AD7DE-4B7D-4FC2-8AB6-0549B49035D1Q34155511-65CC8478-86D3-4A6A-B0CE-4C080241206BQ34170859-416586E4-94EF-45EF-9DB0-BA6F3B5AC8C3Q34189547-34D3A87F-42B0-42FE-AF46-2B8FA9096460Q34244201-D714FF72-A28B-43F0-9C50-06042D5248D0Q34403507-7F183A67-19DB-4907-9BEA-D50C13D9D2AAQ34562623-0A34EB05-2C64-41DA-90D5-2901591A1A7FQ34593855-F61625A5-D7C5-47EA-AD73-FED4C038148AQ34609618-D23949C5-15E4-4395-B873-AEAD6187FF31Q34620111-9D4B82EB-2FCC-4546-B172-D5358BD9DF58Q34636981-7C2A89C0-ECA4-4B0A-B494-F107A8C4AE23Q35096654-9797F6EC-6400-46A4-BE97-4BA94898BC9BQ35161081-3415ED95-9A03-4768-9A32-24705343D478Q35753525-C796C9A5-7D3F-4AD5-B102-4C1DBEC5C294Q35994817-EACE24C8-C85C-4055-82AC-A34C67893C7DQ36205447-4C0BD4AB-4754-4A26-AD62-3FDE769C35A5Q36352109-259E13B8-4681-4F7B-9ED6-7AEC156335D8Q36415177-FAA525A2-D473-426F-95EE-AB0DAA600349Q36480548-0779A491-968A-4F2B-82CD-AF90011770F2Q36497382-52BC9708-E10B-4E84-B1F3-649631401A88Q36679860-421448EC-E55C-4996-BA82-45AA89C9C1CBQ36945968-A1D1DADD-2254-4ECB-8E95-1DBE9226C67FQ37146064-22F86999-0D46-4F72-B38B-8556E8E76DADQ37190518-8CD55475-6CA7-4C91-986A-817E6C9504F8Q37332201-4F1FD410-312F-4217-9A1E-B8EFB5ABC7ADQ37351865-005D9948-A7C7-4A6E-8BCF-DC5C15FA4623Q37352877-1EE10076-F222-4044-9527-595143AEE29DQ37352993-FEB8D8CA-93B1-4943-8292-2ADCA3CFCE6DQ37410064-D61CEFBC-1ED8-4794-9902-70F5A94E6176Q37573529-A2DF7073-ACA8-4156-BB19-E72CE1FBD35E
P2860
Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh-hant
name
Anti-idiotypic suppression of ...... ose intravenous gammaglobulin.
@en
Anti-idiotypic suppression of autoantibodies to factor VIII
@nl
type
label
Anti-idiotypic suppression of ...... ose intravenous gammaglobulin.
@en
Anti-idiotypic suppression of autoantibodies to factor VIII
@nl
prefLabel
Anti-idiotypic suppression of ...... ose intravenous gammaglobulin.
@en
Anti-idiotypic suppression of autoantibodies to factor VIII
@nl
P2093
P921
P1433
P1476
Anti-idiotypic suppression of ...... ose intravenous gammaglobulin.
@en
P2093
M D Kazatchkine
P Maisonneuve
U E Nydegger
P304
P356
10.1016/S0140-6736(84)90701-3
P407
P577
1984-10-01T00:00:00Z